Rep. Dingell Introduces Bipartisan Bill to Eliminate Out-of-Pocket Costs for Breast Cancer Diagnostic Tests
This bill is currently sitting in the House Energy and Commerce and Ways and Means committees. It has not seen any action since April 2025, which means it has been stalled for 14 months. Most bills like this do not receive a committee vote and do not move forward.
This bill has strong bipartisan support and addresses a popular health issue, but it must still navigate the committee process and find time on the busy legislative calendar.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 3851 (118th), which died when its Congress ended.
H.R. 3851 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small businesses that offer group health insurance to employees could see modest increases in insurance premiums as insurers absorb the cost of eliminating cost-sharing for these exams. On the other hand, healthier employees who catch cancer earlier could mean lower long-term healthcare costs and less time away from work. The net financial effect is uncertain but likely small for most businesses.
“In the case of a group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to diagnostic and supplemental breast examinations”
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Members of Congress in both chambers have introduced bipartisan legislation requiring insurers to cover supplemental breast imaging nationwide with no patient cost-sharing. The Access to Breast Cancer Diagnosis Act aims to eliminate financial barriers to imaging access.
Reps. Debbie Dingell and Beth Van Duyne discussed how the government shutdown is halting progress on the Access to Breast Cancer Diagnosis Act. The bill, which eliminates out-of-pocket costs for breast imaging, is popular among voters but faces delays due to legislative gridlock.
Lawmakers in both the U.S. House and Senate have reintroduced bipartisan legislation that would require health insurers to cover supplemental breast imaging services—such as MRI and ultrasound—without patient cost-sharing nationwide.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Access to Breast Cancer Diagnosis Act of 2025
Analysis generated by AI. Always verify with official sources.